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Rhabdomyolysis as a manifestation of a metabolic 
disease: a case report
CASE REPORT
INTRODUCTION
Rhabdomyolysis is characterized by muscle necrosis that results in the 
release of muscles constituents, including myoglobin, into circulation. 
Typically, rhabdomyolysis presents with myalgia, muscle weakness and dark 
urine. However, this triad of symptoms may not always be present in children. 
Clinical manifestations may range from an asymptomatic illness to a life-
threatening condition with highly elevated enzymes, acute renal failure (ARF) 
and electrolyte disturbances.(1,2) Commonly, creatine kinase levels are markedly 
elevated, and myoglobinuria may be present.(1,2) In pediatric patients, infectious 
diseases are the main cause of rhabdomyolysis. However, other etiologies can be 
found and include trauma, exercise, drugs, toxins, and metabolic and electrolyte 
disorders.(1-3) Inherited disorders of carbohydrate metabolism, mitochondrial 
respiratory chain enzyme deficiencies, disorders of fatty acid oxidation and 
deficiency of carnitine palmitoyltransferase are examples of metabolic diseases 
associated with rhabdomyolysis.
We present a case of a previously healthy adolescent that presented with 
massive rhabdomyolysis and was diagnosed with a disorder of fatty acid 
oxidation.
Marta Sousa Moniz1, Maria Inês Mascarenhas1, 
Carlos Escobar1, Pedro Nunes1, Clara Abadesso1, 
Helena Loureiro1, Helena Almeida1
1. Pediatric Intensive Care Unit, Department of 
of Pediatrics, Hospital Prof. Doutor Fernando 
Fonseca, E.P.E - Amadora, Portugal.
Conflicts of interest: None
Submitted on August 16, 2016
Accepted on October 8, 2016
Corresponding author:
Marta Sousa Moniz
Unidade de Cuidados Intensivos Pediátricos do 
Departamento de Pediatria do Hospital Prof. 
Doutor Fernando Fonseca, E.P.E
Morada: IC-19; 2720-276 - Amadora, Portugal
E-mail: marta.moniz@gmail.com
Responsible editor: Jefferson Pedro Piva
Rabdomiólise como manifestação de uma doença metabólica: 
relato de caso
DOI: 10.5935/0103-507X.20170016
Rhabdomyolysis is a process of muscle 
destruction that can present with varying 
clinical manifestations. In pediatric 
patients, its main etiology is infectious 
diseases. We present a previously healthy 
adolescent who was admitted to our 
emergency department with a four-day 
history of myalgia, muscle weakness 
and dark urine. At presentation, she 
was dehydrated. Blood analysis revealed 
acute renal failure and increased muscular 
enzymes.
She was transferred to our pediatric 
intensive care unit. Medical therapies for 
correction of dehydration and the ionic 
and metabolic consequences of renal 
failure were performed. Due to oliguria, 
renal replacement therapy was initiated. 
An etiological investigation revealed a 
beta-oxidation defect. Metabolic diseases 
are a known cause of rhabdomyolysis. 
Muscular destruction should be diagnosed 
early in order to avoid its potential 
consequences. Generally, the treatment of 
rhabdomyolysis is conservative, although 
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CASE REPORT
A 14-year-old girl was admitted to our emergency 
department with a four-day history of generalized 
myalgia, muscular weakness and dark urine. On the 
day of admission, she noted much-reduced diuresis and 
had difficulty walking. During the previous days, the 
patient had been participating in a dance festival in hot 
conditions. There was no past history of muscle cramps or 
hospital admissions due to rhabdomyolysis. She was the 
only child of non-consanguineous parents.
At presentation, she was dehydrated. Her blood 
pressure was 120/60 (90th percentile). Her muscle strengths 
in the proximal and distal muscles of the upper and lower 
extremities were 4/5. Deep tendon reflexes were normal, 
and there was no neurologic deficit. The remainder of her 
physical examination was normal. Her weight was 57kg, 
and her height was 165cm.
The laboratory evaluation revealed ARF with a blood 
urea nitrogen of 263mg/dL (range 19.3 - 44.9mg/dL), a 
blood creatinine of 9.59mg/dL (range 0.60 - 1.30mg/dL) 
and a glomerular filtration rate calculated according to the 
original Schwartz formula of 11.6mL/min/1.73m2. The 
blood gases showed metabolic acidosis (pH 7.30; HCO3 
17.7mmol/L; base excess - 7.9; lactate 1.4mmol/L). 
Blood biochemistries were as follows: sodium 129mmol/L 
(range 136 - 145mmol/L), potassium 6.12 (range 3.4 - 
5.1mmol/L), ionized calcium 1.03mmol/L (range 1.13 
- 1.32mmol/L), phosphorus 9.3mg/dL (3.1 - 5.5mg/
dL), magnesium 1.8mg/dL (range 1.6 - 2.3mg/dL), 
myoglobin 28173mg/dL (range 9 - 82mg/dL), creatine 
kinase > 400,000UI/L (range 28 - 142UI/L), aspartate 
aminotransferase 3266UI/L (range 0 - 26), alanine 
aminotransferase 1310UI/L (range 19 - 44UI/L).
Because of massive rhabdomyolysis, the patient was 
admitted to our pediatric intensive care unit and was given 
intravenous fluid combined with diuretic therapy to reverse 
ARF, glucose and insulin therapy to correct hyperkalemia 
and calcium gluconate to prevent cardiac arrhythmias 
secondary to ion changes. During the first hours of 
admission, she presented anuria that was unresponsive to 
medical therapy. After eight hours of receiving supportive 
therapy, she was started on continuous veno-venous 
hemodiafiltration (Gambro Prismaflex® System, Lisbon; 
Portugal).
A hemodialysis catheter (12F; triple lumen) was 
inserted in the right femoral vein. Hemodiafltration was 
performed using the hemofilter ST 60, and heparin was the 
anticoagulant chosen. The following initial settings were 
used: blood-pump 150mL/min, dialysate (Prismasol 4®) 
1000mL/hr, pre-filter replacement solution (Prismasol 4®) 
500mL/hr, post-filter replacement solution (Prismasol 4®) 
500mL/hr and fluid removal 50mL/hr. During the first two 
days of therapy, the main problem with hemodiafiltration 
was easy coagulability of the hemofilter due to high levels 
of myoglobin in circulation. To overcome this problem, 
higher pre-dilution flow rates were used (maximum 
1500mL/h). After 48 hours, she had asymptomatic 
hypophosphatemia of 2.7mg/dL that was corrected after 
adding phosphorous to the replacement solutions. On day 
5, intermittent hemodialysis was started, and three sessions 
on alternate days were performed. A calcium antagonist 
was prescribed on day six due to worsening hypertension.
Signs and symptoms were controlled with medical 
treatment and renal replacement therapy. Creatinine 
kinase and myoglobin returned to normal values in two 
weeks. Her diuresis started to recover after the second 
day of therapy. At discharge, her renal function was 
recovering, and she had a glomerular filtration rate of 
88.9mL/min/1.73m2.
Regarding the investigation of the underlying insult, 
an acylcarnitine analysis by tandem mass spectrometry of 
the patient’s dried blood spot revealed a deficiency of very 
long-chain acyl-CoA dehydrogenase (VLCAD). A genetic 
study revealed the following mutations in compound 
heterozygosity of the VLCAD gene: p.P65Tfs*7 (c. 
187_192insA) and p.R336H (c.1097G > A).
Frequent meals with carbohydrate-rich intake before 
exercise and restriction of long-chain fatty acids intake 
along with medium-chain fatty acid supplementation 
were recommended to prevent further attacks.
DISCUSSION
We present the case of an adolescent diagnosed 
with VLCAD deficiency after a massive episode of 
rhabdomyolysis.
VLCAD is an enzyme of fatty acid oxidation found in 
the inner membrane of the mitochondria, and it catalyzes 
the first step of long-chain fatty acid beta-oxidation.(4) Its 
deficiency is inherited as an autosomal recessive trait with 
an incidence of 1:31,500 births.
Depending on the age at presentation (neonatal, 
childhood or adulthood), this disease has different clinical 
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manifestations.(4) The neonatal-onset form manifests as 
liver failure and cardiomyopathy, and the childhood-
onset form is associated with hypoketotic hypoglycemia. 
Our patient presented with the adulthood form, which 
is predominantly characterized by muscle complaints 
due to recurrent episodes of rhabdomyolysis triggered by 
prolonged exercise, infections or fasting.(4)
Although currently VLCAD deficiency is mainly 
diagnosed with the newborn screening card that has 
allowed for earlier diagnosis, different methods can be 
used for its diagnosis, such as chromatographic analysis 
of plasma fatty acids, tandem mass spectrometry analysis 
of acylcarnitines and organic acids analysis in urine.(5,6) In 
Portugal, this disease has been systematically screened for 
in the neonatal screening program since 2006, and our 
patient was born prior to this date.
For VLCAD deficiency, there is no definitive therapy. 
Treatment consists of diet modifications and should 
include a diet low in very long-chain fatty acids with 
supplements of medium-chain triglycerides. Fasting and 
intense exercise should be avoided.(5,6)
Particularly, in the adult form, when a crisis is not 
prevented or interrupted in time, treatment should 
be directed toward reversing rhabdomyolysis and 
its complications. In children, ARF is a recognized 
complication of muscle destruction, and according to a 
recent study, it can occur in 4 - 5.8% of patients with 
rhabdomyolysis.(7) Although the basic mechanism of ARF 
in rhabdomyolysis conditions is not fully understood, one 
proposal is that the myoglobin released from the destroyed 
muscle is the responsible for the renal damage. Renal 
constriction and ischemia, myoglobin cast formation in 
distal tubules and direct myoglobin cytotoxic action in 
the epithelial cells of the proximal tubules are probably 
the main mechanisms underlying ARF.(8) Other potential 
complications of rhabdomyolysis include hyperkalemia 
that may lead to cardiac arrhythmias, metabolic acidosis 
and hypocalcemia, compartmental syndrome and 
asymptomatic disseminated intravascular coagulation.(8)
The major therapeutic interventions in rhabdomyolysis 
are conservative. Initial management should include 
aggressive fluid resuscitation and hydration in order to 
maintain adequate urine output and prevent ARF, early 
correction of potentially lethal electrolyte disturbances 
and correction of metabolic acidosis. Intravenous isotonic 
saline should be started as soon as possible after the onset 
of muscle injury and continued until the injury has 
resolved. Although there is no clear clinical evidence for its 
effectiveness, a forced alkaline diuresis may be performed 
with bicarbonate administration in order to reduce the 
renal toxicity of heme.(2,9) The precipitation of calcium 
phosphate and appearance of hypocalcemia should 
be monitored closely.(9) The best regimen and rate of 
bicarbonate administration are unknown.(9) Fluids should 
be carefully given once ARF and oliguria are present 
in order to avoid non-cardiogenic pulmonary edema. 
Although renal replacement therapy is rarely needed in 
rhabdomyolysis, it should be considered when there is 
severe and resistant hyperkalemia, persistent metabolic 
acidosis, uremia and ongoing ARF despite conservative 
treatments.(8) Daily hemodialysis or continuous renal 
replacement therapy are both options that allow for 
gradual removal of solutes and potassium correction.(10) 
However, both have limited ability to remove myoglobin 
from circulation due to the high molecular weight of 
myoglobin. Recently, based on case series descriptions, 
some authors have proposed performing CRRT with 
hyper-permeable membranes (e.g., super high-flux 
membranes) that allow for removal of molecules with 
higher molecular weights (cut-off 60,000 Da), such as 
myoglobin and cytokines.(11) However, these membranes 
are associated with excessive albumin loss. Our patient 
used a standard filter, which had the main problem of easy 
coagulability in the first few days of treatment. This problem 
was attributed to the high circulating levels of myoglobin 
that obstructed the membrane pores. Peritoneal dialysis is 
inadequate to remove the large solute load in patients with 
rhabdomyolysis. Other complications of rhabdomyolysis, 
such as compartment syndrome, should be monitored, 
and surgical decompression should be performed as soon 
as needed. The treatment of disseminated intravascular 
coagulation is mainly supportive and depends on the 
overall treatment of rhabdomyolysis.
CONCLUSION
Very long-chain acyl-CoA dehydrogenase deficiency is 
a disease that has the worst prognosis when it is diagnosed 
in the newborn period. The adult form has a good 
prognosis if rhabdomyolysis is avoided. Once in advanced 
stages, rhabdomyolysis can lead to life-threatening 
complications.
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A rabdomiólise é um processo de destruição muscular com 
manifestações clínicas variáveis. Em pacientes pediátricos, tem 
como principal etiologia as doenças infecciosas. Apresentamos 
o caso de uma adolescente previamente saudável, que foi ad-
mitida ao nosso pronto-socorro com histórico de 4 dias com 
mialgia, fraqueza muscular e urina escura. Na avaliação inicial, 
apresentava-se desidratada. Os exames de sangue revelaram in-
suficiência renal aguda e aumento de enzimas musculares. A 
paciente foi transferida para nossa unidade de terapia intensi-
va pediátrica. Foi realizado tratamento clínico para correção da 
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desidratação e das consequências iônicas e metabólicas da insu-
ficiência renal. Em razão da oligúria, deu-se início à terapia de 
substituição renal. A investigação etiológica revelou um defeito 
da betaoxidação. Sabe-se que doenças metabólicas podem pro-
vocar rabdomiólise. A destruição muscular deve ser identificada 
precocemente, para evitar suas potenciais consequências. Em 
geral, o tratamento da rabdomiólise é conservador, embora em 
algumas situações seja necessária uma abordagem mais invasiva.
